# FDA Inspection 1141386 - Baptist Health Lexington IRB - April 29, 2021

Source: https://www.keypedia.com/records/fda_inspections/baptist-health-lexington-irb/fe35b6fa-4f3a-448b-a431-99aae8f656fc
Source feed: FDA_Inspections

> FDA Inspection 1141386 for Baptist Health Lexington IRB on April 29, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1141386
- Company Name: Baptist Health Lexington IRB
- Inspection Date: 2021-04-29
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs

## Related Documents

- [FDA Inspection 1141386 - 2021-04-29](https://www.keypedia.com/records/fda_inspections/baptist-health-lexington-irb/037c9348-94f3-4a52-a736-9434045703ac)
- [FDA Inspection 1141386 - 2021-04-29](https://www.keypedia.com/records/fda_inspections/baptist-health-lexington-irb/44383934-7891-46ac-b465-3253878992da)
- [FDA Inspection 859243 - 2013-11-22](https://www.keypedia.com/records/fda_inspections/baptist-health-lexington-irb/91cb337a-edb2-49fa-86d3-fa0efd06b4e0)

Company: https://www.keypedia.com/companies/baptist-health-lexington-irb/dbf99046-717b-4ad2-a1ee-b6ef12ec57ab